15
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Hemochromatosis: New Insights in Pathogenesis and Diagnosis Following the Discovery of the Gene

Pages 239-273 | Published online: 29 Sep 2008

REFERENCES

  • Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nature Genetics 1996; 13: 399–408.
  • Sheldon JH. Haemochromatosis. Pp. 164–340. Oxford Medical Publications, 1935.
  • Simon M, Bourel M, Genetet B, et al. Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing. N Engl J Med. 1977; 297: 1017–21.
  • Merryweather-Clarke A, Pointon J, Sherman J, et al. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275–8.
  • Fleming M, Trenor C, Su M, Foernzler D, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nature Genetics 1997; 16: 383–6.
  • Gunshin H, Mackenzie B, Berger U, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482–8.
  • Klausner RD, Rouault TA Harford JB. Regulating the fate of mRNA: The control of cellular iron metabolism. Cell 1993; 72: 19–28.
  • Pietrangelo A, Casalgrandi G, Quaglino D, et al. Duodenal ferritin synthesis in genetic hemochromatosis. Gastroenterology 1995; 108: 208–17.
  • Flanagan PR, Hajdu A Adams PC. Iron regulatory element binding protein in hemochromatosis liver and intestine. Hepatology 1995; 22: 828–32.
  • Zhou XY, Tomatsu S, Fleming R, et al. Knockout of the mouse HFE gene produces hemochromatosis. Proc Natl Acad Sci USA 1998; 95: 2492–97.
  • Feder J, Tsuchihashi Z, Irrinki A, et al. The hemochromatosis founder mutation in HLA-H disrupts beta-2-microglobulin interaction and cell surface expression. J Biol Chem 1997; 272: 14025–8.
  • Parkkila S, Waheed A, Britton R, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 1997; 94: 13198–202.
  • Feder J, Penny D, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998; 95: 1472–7.
  • Sciot R, Paterson AC, Van Den Oord JJ, et al. Lack of hepatic transferrin receptor expression in hemochromatosis. Hepatology 1987; 7: 831–7.
  • Adams PC, Chau LA, White M, et al. Expression of transferrin receptors on monocytes in hemochromatosis. Am J Hematol 1991; 37: 247–52.
  • Banerjee D, Flanagan PR, Cluett J, et al. Transferrin receptors in the human gastrointestinal tract. Relationship to body iron stores. Gastroenterology 1986; 91: 861–9.
  • Toyokuni S, Sagripanti JL. Iron-mediated DNA damage — sensitive detection of DNA strand breakage catalyzed by iron. J Inorganic Biochemistry 1992; 47: 241–8.
  • Adams PC, Deugnier Y, Moirand R, et al. The relationship between iron overload, clinical symptoms and age in 410 patients with genetic hemochromatosis. Hepatology 1997; 25: 162–6.
  • Moirand R, Adams PC, Bicheler V, et al. Clinical features of genetic hemochro-matosis in women compared to men. Ann Int Med 1997; 127: 105–10.
  • Adams PC. Hepatocellular carcinoma in hereditary hemochromatosis. Can J Gastroenterol 1993; 7: 37–41.
  • Hramiak I, Finegood D Adams PC. Factors affecting glucose tolerance in hereditary hemochromatosis. Clin Invest Med 1997; 20: 110–8.
  • Niederau C, Berger M, Stremmel W, et al. Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation. Diabetologia 1984; 26: 441–4.
  • Kaltwasser JP, Schalk KP Werner E. Juvenile hemochromatosis. Ann NY Acad Med 1988; 526: 339–41.
  • Adams PC, Speechley M. The effect of arthritis on the quality of life in hereditary hemochromatosis. J Rheumatol 1996; 23: 707–10.
  • Diamond T, Stiel D Posen S. Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 1989; 110: 430–6.
  • Cullen LM, Sommerville L, Crawford DHG, et al. The haemochromatosis defect in Australia: population frequency indicates level of expression and positive selection for the defect. [Abstract] Blood 1998; (in press).
  • Adams PC, Valberg LS. Evolving expression of hereditary hemochromatosis. Sem Liv Dis 1996; 16: 47–54.
  • Balan V, Baldus W, Fairbanks V, et al. Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients. Gastroenterology 1994; 107: 453–9.
  • Brissot P, Bourel M, Herry D, et al. Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology 1981; 80: 557–65.
  • Adams PC, Kertesz AE Valberg LS. Clinical presentation of hemochromatosis: a changing scene. Am J Med 1991; 90: 445–9.
  • Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemo-chromatosis: evolution of diagnostic criteria. Gastroenterology 1998; 114: 319–23.
  • Adams PC, Deugnier Y, Moirand R, et al. Relationship between age, ferritin, and cirrhosis in genetic hemochromatosis: implications for liver biopsy. [Abstract] Hepatology 1997; 26: 468A
  • Adams PC, Speechley M Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991; 101: 368–72.
  • Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107–19.
  • Fargion S, Mandelli C, Piperno A, et al. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992; 15: 655–9.
  • Bassett ML, Halliday JW Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6: 24–9.
  • Adams PC, Bradley C Henderson AR. Evaluation of the hepatic iron index as a diagnostic criterion in hereditary hemochromatosis. J Lab Clin Med 1997; 130: 509–14.
  • Ludwig J, Hashimoto E, Porayko M, et al. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997; 112: 882–8.
  • Guyader D, Gandon Y, Robert JY, et al. Magnetic resonance imaging and assessment of liver iron content in genetic hemochromatosis. J Hepatol 1992; 15: 304–8.
  • Adams PC, Kertesz AE. Human leukocyte antigen typing of siblings in hereditary hemochromatosis: a cost approach. Hepatology 1992; 15: 263–8.
  • Jazwinska EC, Pyper WR, Burt MJ, et al. Haplotype analysis in Australian hemochromatosis patients: evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis. Am J Hum Genet 1995; 56: 428–33.
  • Stone C, Pointon JJ, Jazwinska EC, et al. Isolation of CA dinucleotide repeats close to d6s105; linkage disequilibrium with haemochromatosis. Hum Mol Genet 1994; 3: 2043–6.
  • Jouanolle A-M, Gandon G, Jezequel P, et al. Haemochromatosis and HLA-H. Nature Genetics 1996; 14: 251–2.
  • The UK Haemochromatosis Consortium. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997; 41: 841–5.
  • Bacon BR, Schratz C, Britton RS, et al. Presence of the hemochromatosis genotype in patients with liver disease. [Abstract] Gastroenterology 1997; 112: A1218
  • Minguillan J, Lee R, Britton R, et al. Genetic markers for hemochromatosis in patients with cirrhosis and iron overload. [Abstract] Hepatology 1997; 26: 158A
  • Adams PC. Implications of genotyping of spouses to limit investigation of children in genetic hemochromatosis. Clinical Genetics 1998 53: 176–8.
  • Carella M, D’Ambrosio L, Totaro A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997; 60: 828–32.
  • Adams PC. Factors affecting rate of iron mobilization during venesection therapy for hereditary hemochromatosis. Am J Hematology 1998; 58: 16–19.
  • Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993; 328: 1616–20.
  • Powell LW. Hemochromatosis: the impact of early diagnosis and therapy. Gastroenterology 1996; 110: 1304–7.
  • Edwards CQ, Griffen LM, Goldgar D, et al. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988; 318: 1355–62.
  • Velati C, Piperno A, Fargion S, et al. Prevalence of idiopathic hemochromatosis in Italy: study of 1301 blood donors. Haematologica 1990; 75: 309–12.
  • Wiggers P, Dalhoj J, Kiaer H, et al. Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med 1991; 230: 265–70.
  • Adams PC, Kertesz AE, Barr R, et al. Population screening for hemochromatosis with the unbound iron binding capacity. [Abstract] Gastroenterology 1998; 114: A1199.
  • Hallberg L, Bjorn-Rasmussen E Jungner I. Prevalence of hereditary haemochromatosis in two Swedish urban areas. J.Intern.Med. 1989; 225: 249–55.
  • Baer DM, Simons JL, Staples RL, et al. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med 1995; 98: 464–8.
  • Leggett BA, Halliday JW, Brown NN, et al. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 1990; 74: 525–30.
  • O’Brien T, Barrett B, Murray DM, et al. Usefulness of biochemical screening of diabetic patients for hemochromatosis. Diabet Care 1990; 13: 532–4.
  • Olsson KS, Marsell R, Ritter B, et al. Iron deficiency and iron overload in Swedish male adolescents. J Intern Med 1995; 237: 187–94.
  • Olynyk J, Marshall H, Crostella L, et al. Population screening for the hemochro-matosis mutation and biochemical expression. [Abstract] Hepatology 1997; 26: 199A
  • Buffone GJ, Beck JR. Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis. Clin Chem 1994; 40: 1631–6.
  • Phatak PD, Guzman G, Woll JE, et al. Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med 1994; 154: 769–76.
  • Adams PC, Gregor JC, Kertesz AE, et al. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a thirty-year database. Gastoenterology 1995; 109: 177–88.
  • Kowdley K, Kaur S Hassanien T. Primary liver cancer and survival in patients undergoing orthotopic liver transplantation for hemochromatosis. J Liver Trans Surg 1995; 1: 237–41.
  • Porter DR, Sturrock RD Capell HA. The use of serum ferritin estimation in the investigation of anaemia in patients with rheumatoid arthritis. Clin Exp Rheumatol 1994; 12: 179–82.
  • Kaye TB, Guay AT. Increased Serum Ferritin Levels in Patients with Diabetes Mellitus. Mayo Clin Proc 1994; 69: 498–9.
  • Cohen C, Berson SD, Shulman G, et al. Liver iron stores and hepatitis B antigen status. Cancer 1985; 56: 2202–4.
  • LeSage GD, Baldus WP, Fairbanks VF, et al. Hemochromatosis: genetic or alcohol-induced? Gastroenterology 1983; 84: 1471–7.
  • Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings. Hepatology 1996; 23: 724–7.
  • Boucher E, Bourienne A, Adams PC, et al. Liver iron concentration and distribution during therapy for chronic hepatitis C. Gut 1997; 41: 115–20.
  • Bacon BR. Iron and hepatitis C. Gut 1997; 41: 127–8.
  • Edwards CQ, Griffen LM, Goldgar DE, et al. HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda. Gastroenterology 1989; 97: 972–81.
  • Beaumont C, Fauchet R, Phung LN, et al. Porphyria cutanea tarda and HLA-linked hemochromatosis. Evidence against a systematic association. Gastroen-terology 1987; 92: 1833–8.
  • Beutler E. Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations. Lancet 1997; 349: 296–7.
  • Stuart K, Busfield F, Jazwinska E, et al. The C282Y mutation in HFE is common in Australian patients and can act indepedently of HCV to precipitate porphyria cutanea tarda. [Abstract] Hepatology 1997; 26: 606A
  • Gordeuk V, Mukiibi J, Hasstedt SJ, et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med 1992; 326: 95–100.
  • Adams PC, Bradley C Frei JV. Hepatic iron and zinc concentrations after portacaval shunting for nonalcoholic cirrhosis. Hepatology 1994; 19: 101–5.
  • Moirand R, Mortaji A, Loreal O, et al. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997; 349: 95–7.
  • Wurapa RK, Gordeuk V, Brittenham G, et al. Primary iron overload in African Americans. Am J Med 1996; 100: 9–18.
  • Eason RJ, Adams PC, Aston CE, et al. Familial iron overload with possible autosomal dominant inheritance. Aust NZ J Med 1990; 20: 226–30.
  • Oliver M, Scully L, Guiraudon C, et al. Non-HLA linked hemochromatosis in a Chinese woman. Dig Dis Sci 1995; 40: 1589–91.
  • Egawa H, Berquist W, Garcia-Kennedy R, et al. Rapid development of hepato-cellular siderosis after liver transplantation for neonatal hemochromatosis. Transplantation 1997; 62: 1511–3.
  • Cazzola M, Bergamaschi G, Tonon L, et al. Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA. Blood 1997; 90: 814–21.
  • Girelli D, Corrocher R, Biscelglia L, et al. Hereditary hyperferritinemia-cataract syndrome caused by a 29-base pair deletion in the iron responsive element of ferritin L-subunit gene. Blood 1997; 90: 2084–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.